MIR4273: A Potential Drug Target and Biomarker (G100422955)
MIR4273: A Potential Drug Target and Biomarker
Molecular Targets in Communications (MITOMETRICS)
MITOMETRICS is a peer-reviewed scientific journal that publishes original research articles, reviews, and case reports on all aspects of molecular targets and their clinical applications. The journal aims to provide a forum for researchers, clinicians, and other healthcare professionals to exchange knowledge and ideas on the latest developments in the field of molecular targets and related topics.
In this article, we discuss the potential drug target and biomarker, MIR4273, and its implications in the field of pharmacology.
MIR4273 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. MIR4273 is a key regulator of the hematopoietic stem cell (HSC) proliferation and differentiation, and its deregulation has been associated with a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
Studies have shown that MIR4273 plays a crucial role in the regulation of stem cell proliferation and differentiation by controlling the expression of key genes involved in the cell cycle, apoptosis, and angiogenesis. MIR4273 has also been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion, as well as in the regulation of inflammation and immune cell function.
Given its involvement in a wide range of cellular processes, MIR4273 has great potential as a drug target. Researchers have been exploring the use of small molecules, RNA interference, and gene editing techniques to target MIR4273 and its downstream targets. Some studies have shown that MIR4273 can be effectively targeted with small molecules that bind to specific MIR4273 binding sites, such as those found in the N-terminal and C-terminal regions of the molecule.
In addition to its potential as a drug target, MIR4273 has also been identified as a potential biomarker for a variety of diseases. Studies have shown that MIR4273 is significantly upregulated in a variety of cancer types, including breast, lung, and ovarian cancers. This increase in MIR4273 expression has been associated with poor prognosis and poor clinical outcomes in cancer patients.
Furthermore, MIR4273 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. MIR4273 has been shown to play a role in the regulation of neurotransmitter synthesis and release, as well as in the regulation of glial cells, which are important for the support and maintenance of nerve cells.
In conclusion, MIR4273 is a promising drug target and biomarker with great potential for the development of new therapies for a variety of diseases. Further research is needed to fully understand the mechanisms of MIR4273's role in cellular processes and its potential as a drug target.
Protein Name: MicroRNA 4273
The "MIR4273 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4273 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454
